Urological cancer, Malmö
1 – 10 of 579
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Improved sex-specific cardiovascular risk prediction with multi-omics data in people with type 2 diabetes
- Contribution to journal › Article
-
Mark
Risk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits : Evidence and Implications for Europe
- Contribution to journal › Debate/Note/Editorial
-
Mark
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer : Findings from the International, Multicenter PROMISE Registry
- Contribution to journal › Article
-
Mark
Remote symptom monitoring with clinical alerts following lumpectomy : do alerts predict 30-day re-operation or re-admission rates?
- Contribution to journal › Article
-
Mark
Fosfomycin versus ciprofloxacin for transrectal prostate biopsy : An open randomised controlled multicentre drug trial
- Contribution to journal › Article
-
Mark
Prognostic value of tumour volume based on [18F]PSMA-1007 PET/CT in prostate cancer
- Contribution to journal › Article
-
Mark
Factors associated with potentially inappropriate medication use, medication underuse and overuse in older adults in the German National Cohort
- Contribution to journal › Article
-
Mark
Variation in diagnostic performance of fecal immunochemical test (FIT) by cutoffs used in screening programs globally
- Contribution to journal › Article
-
Mark
Treatment with CernitinTM of induced urinary bladder inflammation downregulates relevant pro-inflammatory biomarkers - an experimental in vivo rodent model
- Contribution to journal › Article
-
Mark
New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study
- Contribution to journal › Article
